Reduced irradiation exposure areas enhanced anti-tumor effect by inducing DNA damage and preserving lymphocytes | Molecular Medicine | Full Text
HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models | Scientific Reports,Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review),Reduced irradiation exposure areas enhanced anti-tumor effect by inducing DNA damage and preserving lymphocytes | Molecular Medicine | Full Text,Frontiers | The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers